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1256Objectives: Tricuspid valve annuloplasty (TVP) has been advocated concomitantly with left-sided cardiac
surgery in case of more than moderate tricuspid regurgitation (TR) or tricuspid annular dilation (TAD) (diameter
>40 mm or 21 mm/m2) even in the absence of significant TR. Data on postoperative right ventricular (RV)
remodeling are lacking in such patients.
Methods: Preoperative and postoperative echocardiography data from 45 consecutive TVP procedures,
performed in mitral valve surgery in a single tertiary center, were retrospectively analyzed and compared
with a propensity-matched control group of 33 procedures without concomitant TVP. RV function and geometry
was analyzed by measuring RV size, fractional area change, and end-diastolic sphericity index (RVSI ¼ long-
axis length/short-axis width) and compared at baseline versus follow-up.
Results: At a mean follow-up of 5 months, a favorable change in RV geometry was observed in TVP patients
(RVSI increased from 1.99  0.33 to 2.21  0.42; P ¼ .001), whereas the opposite was observed in the control
group (RVSI decreased from 2.34  0.52 to 2.17  0.13; P ¼ .05). Only in control patients, indexed RV end-
diastolic area increased significantly (P ¼ .003). In TVP patients, when comparing patients with baseline more
than moderate TR (n ¼ 13) to patients with isolated TAD (n ¼ 32), there was a significant decrease in RV
end-diastolic area only in the group with more than moderate TR (from 12.9  3.5 cm2/m2 to 10.3  1.9
cm2/m2; P ¼ .009).
Conclusions: Adding TVP to mitral valve surgery in patients with more than moderate TR or TAD leads to fa-
vorable changes in RV geometry and prevents postoperative RV dilation. This is most pronounced in patients
with more than moderate TR at baseline. (J Thorac Cardiovasc Surg 2014;147:1256-64)De novo or progressive tricuspid regurgitation (TR) after
successful left-sided heart surgery is commonly observed
and associated with increased morbidity and mortality.1-3
Therefore, tricuspid valve annuloplasty (TVP) has been
advocated to be performed concomitantly in case of more
than moderate TR (TR>2þ) and, more recently, also in
case of tricuspid annular dilation (TAD, defined as
a tricuspid annular diameter >40 mm or 21 mm/m2),
irrespectively of TR.4,5 The rationale for performing TVP,
even in patients with TAD but without significant TR (TR
2þ), relies on evidence that TAD is an ongoing disease
process that over time often leads to severe functional
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The Journal of Thoracic and Cardiovascular Surventricular (LV) geometry and function in patients with se-
vere mitral regurgitation (MR) has been extensively stud-
ied,7-13 data on right ventricular (RV) geometry and
function changes in response to TVP are surprisingly
scarce. Although results have shown that mitral valve
repair (MVP) induces reverse LV remodeling in a gradual
and time-dependent fashion, it is not known whether TVP
has similar beneficial effects on RV shape and function. Fur-
thermore, it is not known whether the effects of TVP are dif-
ferent for patients with severe coexistent TR compared with
those in whommere TADwas the reason to intervene on the
tricuspid valve.
Therefore, the objectives of this study were as follows:
(1) to determine the differential effects on RV size, geome-
try, and function of TVP performed because of severe TR
versus TAD without significant TR in patients scheduled
for mitral valve surgery and (2) to compare the echocardiog-
raphy data of this population with data from a propensity-
matched cohort of patients undergoing similar procedures
without TVP.METHODS
Study Population
Figure 1 summarizes the study flow chart. Between July 2007 and De-
cember 2011, 316 mitral valve procedures of any kind were performed atgery c April 2014
Abbreviations and Acronyms
LV ¼ left ventricular
MR ¼ mitral regurgitation
MVP ¼ mitral valve repair
MVR ¼ mitral valve replacement
RV ¼ right ventricular
RVFAC ¼ right ventricular fractional area change
RVSI ¼ right ventricular sphericity index
TAD ¼ tricuspid annular dilation
TR ¼ tricuspid regurgitation
TVP ¼ tricuspid valve annuloplasty
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(MVP) or replacement (MVR) procedures in all patients, with a proportion
of patients receiving concomitant coronary artery bypass grafting and/or
concomitant aortic valve surgery. Concomitant TVP was systematically
performed in 137 patients, when more than moderate TR (TR>2, ie, color
Doppler jet area/atrial area>20%14) and/or TAD (tricuspid annular diam-
eter>40mmor>21mm/m2) was present. Only patients with complete pre-
operative and postoperative (3-6 months) echocardiography data and
examinations performed at our center were included in the analysis. The
TVP population thus consisted of 45 consecutive patients who underwent
TVP together with left-sided heart surgery. There were no patients with
structural (organic) tricuspid valve disease in the study population. From
the remaining 53 patients undergoing mitral valve surgery without con-
comitant TVP, we recruited a control population of 33 patients by using
propensity matching for age, gender, LV ejection fraction, LV end-
diastolic volume, and cardiopulmonary bypass time. The study was ap-
proved by the locally appointed ethics committee, which waived the
need for individual consent owing to the retrospective and observational
nature of the study.
Surgical Procedure
All surgical procedureswere performed throughmidline sternotomy un-
der normothermic cardiopulmonary bypass with intermittent antegrade
warm blood cardioplegia. Patients with an indication for revascularization
underwent coronary artery bypass grafting first. Subsequently, the mitral
valve was exposed through a vertical transseptal approach along the right
border of the foramen ovale, leaving the left atrial roof untouched. In pa-
tients with structural mitral valve disease, MVP was performed after thor-
ough intraoperative visual and echocardiographic valve analysis according
to standard Carpentier techniques.15 In patients in whom the mitral valve
was deemed irreparable, MVR was performed. Mitral annuloplasty ring
size was determined after careful measurement of the height of the anterior
leaflet; in patients with functional MR, downsizing by 2 sizes (ie, size 26
when measuring 30) of a complete semirigid annuloplasty ring (Carpent-
ier-Edwards Physio Ring; Edwards Lifesciences, Irvine, Calif) was rou-
tinely performed. In patients with severe degenerative aortic valve
disease, aortic prosthetic valve replacement was performed if indicated.
TVP was subsequently performed, also on normothermic cardiopulmonary
bypass with intermittent antegrade warm blood cardioplegia, with a Car-
pentier-Edwards MC3 ring (Edwards Lifesciences) using the surface of
the anterior leaflet as a reference. In patients with severe tricuspid valve
leaflet tethering (ie, 8-mm tethering distance), an additional pericardial
patch augmentation of the anterior leaflet was performed to increase tricus-
pid leaflet coaptation.16 The restored leaflet coaptation was confirmed at
the time of surgery by filling the RV and/or LV with saline through
a bulb syringe and by visually inspecting the leaflets. Additionally, afterThe Journal of Thoracic and Carweaning from cardiopulmonary bypass, intraoperative transesophageal
echocardiography was used to assess the result of the valve reconstructions.
Transthoracic Echocardiography
Comprehensive 2-dimensional echocardiography examinations were
performed with a commercially available system (IE33; Philips Medical
Systems, Andover, Mass). Standard 2-dimensional and Doppler echocar-
diographic images were acquired in the left lateral decubitus position using
a phased-array transducer in the parasternal and apical views by experi-
enced cardiac sonographers. Three consecutive cardiac cycles were re-
corded and stored for subsequent offline analysis. LV end-diastolic and
end-systolic dimensions were measured from parasternal acquisitions.
LV volumes and ejection fraction were calculated using Simpson’s biplane
method according to the guidelines of the American Society of Echocardi-
ography.17 Left and right atrial areas were measured by planimetry at
end-systole from the apical 4-chamber views. Left atrial volumes were
measured by Simpson’s biplane method. Color flow was applied in the
apical 4-chamber view to assess severity of TR, which was graded semi-
quantitatively on a scale from 0 to 4 as follows: 0, none or trace; 1þ, jet
area/atrial area<10% (mild TR); 2þ, jet area/atrial area 10% to 20%
(moderate TR); 3þ, jet area/atrial area 20% to 33% (moderate-to-severe
TR); and 4þ, jet area/atrial area>33% (severe TR).14,18 From the apical
4-chamber view, the RV end-systolic and end-diastolic areas were
measured by planimetry with the transducer positioned to maximize the
RV area and to include the RV apex. RV fractional area change
(RVFAC) was used to determine RV systolic function and was calculated
by the following formula: FAC¼ ([diastolic area systolic area]/diastolic
area)3 100%.19 RV long-axis length and RV short-axis width at the mid-
ventricular level were measured as described by Matsunaga and Duran20
and used to calculate the end-diastolic RV sphericity index as previously
described (RVSI ¼ RV long-axis length/RV short-axis width).21 Systolic
pulmonary artery pressure was measured by echocardiography using the
modified Bernoulli equation on the transtricuspid continuous-wave Dopp-
ler signal, while adding right atrial pressure. In a minority of patients with
no transtricuspid Doppler signal on preoperative echocardiography, sys-
tolic pulmonary artery pressure was adapted from preoperative right heart
catheterization.
Statistical Analysis
Results are expressed as mean standard deviation for continuous vari-
ables and as percentages for categorical variables. Continuous variables
were compared using the 2-tailed Student t test or the Wilcoxon signed
rank test when the normality test failed. Categorical values were compared
using the Fisher exact test. Interobserver and intraobserver agreement for
RVFAC and RVSI measurement was tested by Bland-Altman analysis. Sta-
tistical analyses were performed using the Statistical Package for Social
Sciences release 20.0 (SPSS, Inc, Chicago, Ill). We had full access to the
data and take responsibility for its integrity. All of us have read and agreed
to the manuscript as written.RESULTS
Patient Characteristics
Baseline characteristics of the patients are summarized in
Table 1. Mitral valve disease was the primary indication for
cardiac surgery in both groups: 40 (89%) patients and 27
(82%) patients underwent MVP in the TVP and control
groups, respectively, whereas 5 (11%) patients and 6
(18%) patients needed MVR in both groups, respectively.
In the TVP group, 29% of TVP procedures were performed
because of more than moderate (>2þ) preoperative func-
tional tricuspid insufficiency and 71% because of TADdiovascular Surgery c Volume 147, Number 4 1257
FIGURE 1. Study flow chart. RV, Right ventricular; TVP, tricuspid valve
annuloplasty; LV, left ventricular.
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TR. Pericardial patch augmentation of the anterior leaflet
was performed in 2 (4%) TVP patients. There was a signif-
icant difference in baseline right and left atrial dimensions
between the 2 groups, likely explaining a higher incidence
of atrial fibrillation in TVP patients, accounting for a rela-
tively higher rate of maze procedures in this group and a dif-
ference in baseline anticoagulation therapy. Valvular repair
was successful with residual MR/TR 1þ in all patients as
noted by periprocedural transesophageal echocardiography.
Mortality at 3 months in the 197 patients with follow-up at
our center was 15.1% (13/86) in the TVP group and 10.8%
(12/111) in the control group.Echocardiographic Remodeling
Preoperative and postoperative echocardiography data
are shown in Table 2. Postoperative data were obtained after
a mean follow-up of 4.9 3.0 months in the TVP group and
4.5  2.6 months in the control group. A favorable change
in RV geometry was observed in the TVP group as RVSI1258 The Journal of Thoracic and Cardiovascular Surincreased from 1.99  0.33 to 2.21  0.42 (P< .001,
Figure 2); that is, the RV became significantly less spheri-
cal. The opposite was observed in the control group, where
the RVSI decreased from 2.34  0.52 to 2.17  0.13
(P ¼ .05) after mitral valve surgery. Indexed RV end-
diastolic area increased significantly in the control group af-
ter surgery (from 10.3  1.9 to 11.7  2.6 cm2/m2;
P ¼ .003) but remained unchanged in the TVP group
(from 12.0  3.5 to 11.8  3.6 cm2/m2, P ¼ .7). Further-
more, there was a nonsignificant decrease in RV contractile
function, as measured by RVFAC, after surgery in both
groups (from 40.9%  12.1% to 37.5%  14.0% in
TVP patients and from 44.2%  11.1% to 40.6% 
10.2% in control patients; P¼ .1 and P¼ .08, respectively).
TR grade decreased significantly in the TVP group after
surgery (from 2.0  1.1 to 0.5  0.7; P<.001), whereas
a slight but significant increase in TR was noted in the con-
trol group at follow-up (from 0.5  0.7 to 1.2  1.1;
P ¼ .001), as depicted in Table 2. In control patients, in-
dexed tricuspid annular dimensions increased significantly
(from 1.91  0.39 cm/m2 to 2.08  0.33 cm/m2;
P ¼ .003), with progression toward more than moderate
TR in 4 (12%) patients. LV dimensions and function re-
mained overall unchanged in both groups.
When RV geometry and function after surgery in TVP
patients were compared with more than moderate TR
(n¼ 13) versus TAD without significant TR (n¼ 32), a sig-
nificant increase in RVSI was noted in both groups (from
1.90  0.33 to 2.13  0.41, and from 2.02  0.32 to 2.24
 0.43; P ¼ .04 and P ¼ .007, respectively) (Table 3). Fur-
thermore, there was a significant decrease in RV end-
diastolic area only in the group with more than moderate
TR (Figure 2). RVFAC declined significantly in patients
with more severe TR at baseline, whereas it remained rela-
tively unchanged in those undergoing TVP because of TAD
(from 42.5% 8.8% to 35.6% 6.9% and from 40.2%
13.3% to 38.3% 9.6%; P¼ .02 and P¼ .5, respectively).
Determinants of Postoperative RV Size and Function
In both patient groups, substantial variance in the differ-
ence between preoperative and postoperative RVFAC and
RV end-diastolic area could be observed (Figure 3). To
find possible determinants of these postoperative changes,
we performed a univariable logistic regression analysis on
the entire study population (TVP and control patients), after
dichotomization into presence/absence of>5% postopera-
tive increase in RV end-diastolic area and>10% decrease
in RVFAC, that is, dichotomization at the level of the me-
dian. Among the many variables evaluated in the regression
analysis were age at operation, cardiopulmonary bypass
time, aortic clamp time, baseline medication, medical his-
tory, preoperative systolic pulmonary artery pressure, base-
line RVFAC, RVSI, and RV end-diastolic area. This
analysis, however, yielded no statistically significantgery c April 2014
TABLE 1. Baseline population characteristics
Variables TVP group (n ¼ 45) Control group (n ¼ 33) P value
Age, y 68  11 69  8 .8
Male gender 17 (52%) 22 (49%) 1.0
Body surface area, m2 1.77  0.21 1.77  0.20 .9
NYHA class 2.67  0.76 2.49  0.84 .3
Cardiovascular risk factors
Diabetes 9 (20%) 9 (27%) .6
Hypertension 24 (53%) 19 (58%) 1.0
Hyperlipidemia 18 (40%) 17 (52%) .5
Obesity 3 (7%) 5 (15%) .3
Smoking habits 15 (33%) 15 (45%) .5
COPD 8 (18%) 10 (30%) .28
CKD 8 (18%) 4 (12%) .56
Familial history of ischemia 10 (22%) 10 (30%) .6
Baseline medication
ACE-I/ARB 20 (44%) 25 (76%) .01
Beta-blockers 33 (73%) 24 (73%) 1.0
Loop diuretics 26 (58%) 15 (45%) .4
Spironolactone 12 (27%) 9 (27%) 1.0
Anticoagulation 20 (44%) 6 (18%) .02
Antiplatelet therapy 22 (49%) 28 (85%) .002
Echocardiography data
LV end-diastolic volume, mL 123  52 115  51 .5
LV end-systolic volume, mL 65  45 59  46 .5
LV ejection fraction,% 51  16 54  16 .3
RV end-diastolic area, mm2 21.8  5.8 18.2  3.9 .002
Indexed RV end-diastolic area, cm2/m2 12.0  3.5 10.3  1.9 .010
RVFAC,% 40.9  12.1 44.2  11.1 .2
RVSI 1.99  0.33 2.34  0.52 .001
TR grade 2.0  1.1 0.5  0.7 <.001
Tricuspid annular diameter, cm 4.2  0.6 3.4  0.6 <.001
Tricuspid annular diameter, indexed, cm/m2 2.4  0.4 1.9  0.4 <.001
TR<¼2 (n ¼ 32; 71%) 2.3  0.4 1.9  0.4 <.001
TR>2 (n ¼ 13; 29%) 2.6  0.3 –
Right atrial area, cm2 20  7 16  5 .005
Left atrial area, cm2 27  7 22  5 .001
Systolic pulmonary artery pressure (mm Hg) 47  15 43  15 .4
Operative data
Cardiopulmonary bypass time, min 219  68 210  82 .6
Aortic crossclamp time, min 164  43 151  66 .4
Preoperative atrial fibrillation 19 (42%) 5 (15%) .01
MVP 40 (89%) 27 (82%) .3
MVR 5 (11%) 6 (18%) .3
CABG 20 (44%) 23 (68%) .04
AVR 11 (24%) 6 (18%) .6
Modified maze procedure 15 (33%) 3 (9%) .02
Etiology of mitral valve disease
Organic (Carpentier class II/IIIa) 21 (47%) 19 (58%) .4
Rheumatic 10 (22%) 8 (24%) 1.0
Degenerative 11 (24%) 11 (33%) .45
Prolapse/flail 5 (11%) 8 (24%) .14
Barlow disease 2 (4%) 0 (0%) .5
Calcific disease 2 (4%) 0 (0%) .5
Endocarditis 2 (4%) 3 (9%) .65
Functional (Carpentier class I/IIIb) 24 (53%) 14 (42%) .4
TVP, Tricuspid valve annuloplasty; NYHA, New York Heart Association; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; ACE-I, angiotensin-
converting enzyme inhibitor; ARB, angiotensin receptor blocker; LV, left ventricular; RV, right ventricular; RVFAC, right ventricular fractional area change; RVSI, right ventricular
sphericity index; TR, tricuspid regurgitation; MVP, mitral valvuloplasty; MVR, mitral valve replacement; CABG, coronary artery bypass graft; AVR, aortic valve replacement.
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TABLE 2. Preoperative and postoperative echocardiography measurements
Variables
TVP group (n ¼ 45) Control group (n ¼ 33)
Baseline Follow-up P value Baseline Follow-up P value
Mean follow-up, mo 4.9  3.0 4.5  2.6 .5
RV end-diastolic area, cm2 21.8  5.8 21.3  5.5 .6 18.2  3.9 20.5  4.6 .002
Indexed RV end-diastolic area cm2/m2 12.0  3.5 11.8  3.6 .7 10.3  1.9 11.7  2.6 .003
RV fractional area change,% 40.9  12.1 37.5  14.0 .1 44.2  11.1 40.6  10.2 .08
RV sphericity index 1.99  0.33 2.21  0.42 .001 2.34  0.52 2.17  0.13 .05
TV annulus diameter, cm 4,2  0.6 TVP 3.4  0.6 3.7  0.5 .006
TV annulus diameter indexed, cm/m2 2.4  0.4 TVP 1.9  0.4 2.1  0.3 .003
TR grade 2.0  1.1 0.5  0.7 <.001 0.5  0.7 1.2  1.2 .001
TR 2, n (%) 32 (71%) 44 (98%) 33 (94%) 29 (88%)
TR>2, n (%) 13 (29%) 1 (2%) <.001 0 (0%) 4 (12%) .01
LV ejection fraction,% 51  16 50  16 .6 54  16 54  15 .9
LV end-diastolic volume, mL 123  52 117  46 .5 115  51 106  45 .3
Right atrial area, cm2 20  7 14  4 <.001 16  5 15  4 .5
Left atrial area, cm2 27  7 23  6 <.001 22  5 21  7 .5
Left atrial volume, mL 97  33 85  32 .01 71  25 65  26 .2
Systolic pulmonary artery pressure, mm Hg 43  17 37  9 .2* 45  16 36  12 .008*
Baseline pulmonary artery pressure data in this table represent the mean  standard deviation only for these 21 and 24 patients, respectively. TVP, Tricuspid valve annuloplasty;
RV, right ventricular; TV, tricuspid valve; TR, tricuspid regurgitation; LV, left ventricular. *Paired samples: only n¼ 21 available in TVP group (owing to difficulty in measurement
of echocardiographic TR signal after TVP), and n ¼ 24 in the control group.
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for decrease in RV function.
Interobserver and Intraobserver Variability
Preoperative and postoperative echocardiographic stud-
ies from 12 randomly selected patients were used to evalu-
ate interobserver and intraobserver variability in the
measurement of RVSI and RVFAC. The results showed
good agreement for both measurements. The mean differ-
ence in RVFAC between different observers was 5.07%
 2.67%; for the same observer, 3.51%  1.43%. The
mean difference in RVSI between different and similar ob-
servers was 0.38  0.24 and 0.22  0.19, respectively.
DISCUSSION
The main finding of the current study is that performing
TVP at the time of mitral valve surgery in patients with
more than moderate TR or TAD without significant TR
leads to favorable changes in RV geometry, with the RV be-
comingmore elliptical and less spherical as illustrated by an
increase in RVSI. These favorable changes did not occur in
a propensity-matched control population. On the contrary,
a significant increase in RV size and sphericity was ob-
served after mitral valve surgery in these patients, along
with progressive TAD and TR. Finally, the effects of TVP
are different for patients with more than moderate preoper-
ative TR compared with patients receiving ‘‘prophylactic
TVP’’ because of TADwithout significant TR. A significant
decrease in RV size, but also in RV systolic function, was
present only in the former subgroup.
Recent observations that TR does not always regress after
successful mitral valve surgery and that occurrence of late1260 The Journal of Thoracic and Cardiovascular SurTR has an adverse impact on exercise capacity, reoperation
rate, and outcome1-3,22,23 have generally encouraged
surgeons to routinely perform TVP at the time of mitral
valve surgery when severe coexistent TR or tricuspid
valve disease is present. In 2005, Dreyfus and associates6
reported on 311 patients undergoing MVP, showing that re-
modeling annuloplasty of the tricuspid valve should be
based on the presence of TAD rather than the grade of
TR. Accordingly, guidelines on the management of valvular
heart diseases underwent further refinement, recommend-
ing correction also for TR 2 in case of significant TAD
(diameter>40 mm or>21 mm/m2).4,5 Our center, which
is an experienced tertiary care and referral center, has
strictly implemented these novel guidelines into daily
clinical practice since 2007. Our current findings suggest
that this strategy has beneficial effects on RV geometry
and remodeling, that is, that TVP may induce
‘‘reshaping’’ of the RV and abolish the asymmetric and
spherical dilation, which is most apparent at end-diastole,
particularly in patients with significant preexisting TR. Re-
storing or preserving a normal RV shape and avoiding dia-
stolic distortion of the interventricular septal geometry
caused by RV volume overload may be an important factor
to maintain or improve LV preload and ejection frac-
tion.24,25 Our results are in accordance with other recently
published data,26,27 demonstrating that TVP performed
concomitantly with MVP effectively inhibits ongoing RV
dilation and associated postoperative TR.
Importantly, our study adds a couple of valuable nuances.
Contrary to what might have been expected, concomitant
tricuspid valve surgery did not lead to a reduction in RV
size in the entire TVP population after 5 months ofgery c April 2014
FIGURE 2. Echocardiographic indices of RV geometry and function at baseline and after 5months of follow-up in the TVP and control group (left column),
and subdivided within the TVP group according to the indication for TVP (right column). CI, Confidence interval; TVP, tricuspid valve annuloplasty;
TR, tricuspid regurgitation; RVSI, right ventricular sphericity index; RVEDA, right ventricular end-diastolic area; RVFAC, right ventricular fractional
area change.
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baseline experienced a decrease in diastolic RV size after
corrective tricuspid valve repair, comparable with what
has been reported in previous studies on the hemodynamic
effects of TVP in patients with severe TR.28,29 Therefore,
our findings indicate a significant correlation between the
preoperative severity of TR and the subsequent change in
end-diastolic RV size, and support previous findings by
Kim and coworkers,28 which showed that the extent of RVThe Journal of Thoracic and Carreverse remodeling after TVP is directly proportional to
the extent of RV volume overload before surgery. In con-
trast, patients with TAD but only mild TR at baseline
exhibited a small (albeit nonsignificant) increase in end-
diastolic RV volume after surgery. Similarly, a decrease in
RV function assessed by RVFAC was seen only in those
with severe preexistent TR. This was anticipated, inasmuch
as RVFAC is an ejection phase index that tends to overesti-
mate ventricular contractile function in the presence ofdiovascular Surgery c Volume 147, Number 4 1261
TABLE 3. Comparison of RV geometry and function within the TVP group
Variables
Baseline TR 2 (n ¼ 32; 71%) Baseline TR>2 (n ¼ 13; 29%)
Baseline Follow-up P value Baseline Follow-up P value
RV end-diastolic area, cm2 21.4  5.6 22.7  5.6 .2 22.6  6.6 18.1  3.5 .01
Indexed RV end-diastolic area, cm2/m2 11.6  3.5 12.5  4.0 .1 12.9  3.5 10.3  1.9 .009
RVFAC,% 40.2  13.3 38.3  9.6 .5 42.5  8.8 35.6  6.9 .02
RVSI 2.02  0,32 2.24  0.43 .007 1.90  0.33 2.13  0.41 .04
RV, Right ventricular; TVP, tricuspid valve annuloplasty; TR, tricuspid regurgitation; RVFAC, right ventricular fractional area change; RVSI, right ventricular sphericity index.
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ming from an increase in preload and decrease in afterload
owing to the low impedance of the right atrium. Neverthe-
less, also in the subgroup of TVP patients receiving TVP be-
cause of TAD, as well as in the control population,
substantial variance was found in postoperative change in
RVFAC, with RV contractile force improving in some, but
deteriorating in others. These findings lead us to believe
that at least in some patients, perhaps more complex proce-
dures (ie, combined mitral and aortic surgery or difficult/
time-consuming repair procedures) with prolonged aortic
crossclamping times, are not well tolerated by the RV, de-
spite adequate intermittent warm blood cardioplegia (in
our patients intermittent cardioplegia of 3 minutes is ap-
plied every 15 minutes). These procedures might occasion-
ally lead to postoperative adverse RV remodeling with
ongoing RV dilation and significant deterioration of RV
function despite correction of the left-sided lesion. Exactly
in these patients, combining left-sided heart surgery with
‘‘prophylactic TVP’’ may prove beneficial at long-term
follow-up and prevent de novo or gradually worsening
TR. Our study lacked statistical power to discriminate dis-
tinct predictors of postoperative size and function, yet
more information is clearly needed to explain why in
some patients the RV is more vulnerable to ischemia/FIGURE 3. Relative postoperative changes in RVEDA and RVFAC in the TV
with baseline more than moderate TR, whereas monochromatic areas indicate
RVFAC, right ventricular fractional area change; TVP, tricuspid valve annulopl
1262 The Journal of Thoracic and Cardiovascular Surreperfusion injury that is probably unavoidable during these
prolonged procedures, despite routine implementation of
protective strategies to prevent myocardial ischemia during
cardioplegic heart arrest.
Once the left-sided lesion(s) have been addressed, a sub-
sequent improvement in cardiac output may increase RV
preload further and also lead to higher end-diastolic RV
volumes, particularly in patients with lesser degrees of
TR preoperatively. Indeed, increased preload and higher
RV end-diastolic volumes may cause RV papillary muscle
displacement and result in severe TR even in the absence
of TAD, as shown recently.30 This subsequent rise in RV
preload may be another important mechanistic cause of re-
current or progressive TR that is frequently observed late
after mitral valve surgery and constitutes the rationale
for our surgeons to consider TVP in patients scheduled
for left-sided heart surgery when TAD is present, despite
absence of significant TR.
Future well-powered studies implementing advanced
imaging modalities and more sophisticated parameters of
RV function are needed to address the complete impact
of concomitant TVP on RV function and geometry, as
well as to determine the impact of TVP on clinical out-
come. These studies should also examine whether it is rea-
sonable to lower the threshold for concomitant TVP evenP and control group. Within the TVP group, dotted areas indicate patients
patients with isolated TAD. RVEDA, Right ventricular end-diastolic area;
asty; TR, tricuspid regurgitation; TAD, tricuspid annular dilation.
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Dfurther once the complexity of left-sided surgery or the an-
ticipated aortic crossclamping time attains a certain level.
Our center has therefore recently initiated a prospective
randomized trial in patients with isolated TAD scheduled
for left-sided heart surgery, with careful clinical follow-
up and systematic dedicated imaging of the right ventricle
at predefined time points (Clinicaltrials.gov identifier:
NCT01580436).
Study Limitations
Obvious limitations inherent in the retrospective study
design should be considered when these findings are inter-
preted. We acknowledge that follow-up duration was short
in our study population and not enough to determine the
long-term effects of TVP concomitant with mitral valve sur-
gery. The sample size was small, with only 25% of all mi-
tral valve procedures analyzed in this study. Furthermore,
inasmuch as our mitral valve population comprised the
whole spectrum of mitral valve disease instead of 1 type
of mitral lesion, we were not able to differentiate the ob-
served beneficial effect of TVP according to the different
types of mitral valve disease. Previous studies have shown
a potential benefit of TVP in patients with functional MR
and rheumatic mitral valve diseases, whereas the effect of
TVP in a degenerative prolapse population remains de-
bated.23,31,32 In addition, our control population could not
be matched to the TVP population with regard to RV
function, geometry, and tricuspid annular dimension
owing to the judicious implementation of the guidelines
regarding concomitant TVP at our center. Finally, it may
be argued that evaluation of RV function using
2-dimensional echocardiography is problematic because
of the complex RV geometry and the sometimes limited
definition of the endocardial surface caused by heavy trabe-
culation. However, analysis was performed on images ac-
quired by experienced personnel, and care was taken to
measure RVFAC (a parameter of RV function that is widely
validated in many previous studies) from a true nonfore-
shortened apical 4-chamber view. Future studies with lon-
ger follow-up using more sophisticated parameters than
RV end-diastolic area or RVFAC (eg, 3-dimensional echo-
cardiography or cardiac magnetic resonance imaging for se-
rial assessment of RV volume and systolic function) are
needed to evaluate the exact effect of TVP on RV size or
function.
CONCLUSIONS
Adding TVP to mitral valve surgery in patients with more
than moderate TR or TAD without significant TR leads to
favorable short-time changes in RV geometry and prevents
ongoing postoperative RV dilation. These changes are most
pronounced in patients with already more than moderate TR
at baseline. Longer follow-up using more sophisticated pa-
rameters is necessary to evaluate the exact mechanisms byThe Journal of Thoracic and Carwhich TVP influences RV remodeling and to evaluate its
effects on clinical outcome.
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